APO Research
Talk to an analyst

APO RESEARCH · REPORT

Macrolide Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Macrolide Drugs Industry Research Report 2026

22 December 2025137 pages

Choose your research edition.

Industry ResearchMacrolide Drugs Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Macrolide Drugs Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Macrolide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Macrolide Drugs Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Macrolide Drugs Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Macrolide Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Macrolide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Macrolide Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Macrolide Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Macrolide Drugs include Teva Pharmaceutical Industries, Sanofi, Merck & Co., Mylan, Pfizer, Fresenius Kabi, WOCKHARDT, Tacorolimus and Sirolimus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Macrolide Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Macrolide Drugs Market by Company

Teva Pharmaceutical Industries

Sanofi

Merck & Co.

Mylan

Pfizer

Fresenius Kabi

WOCKHARDT

Tacorolimus

Sirolimus

Sandoz International

Neo Química

Macrolide Pharmaceuticals

Gland Pharmm

Eli Lilly & Co.

Akorn

Abbott Laboratories

Macrolide Drugs Segment by Type

14-Membered Ring Agents

15-Membered Ring Agents

16-Membered Ring Agents

Ketolides

Macrolide Drugs Segment by Application

Clinics

Hospitalshospital Pharmacies

Hospitals

Online Pharmacies

Retail Pharmacies

Macrolide Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Macrolide Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Macrolide Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Macrolide Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Macrolide Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Macrolide Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Macrolide Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Macrolide Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Macrolide Drugs Sales (k units) of Manufacturers (2021-2026) Table 7. Global Macrolide Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Macrolide Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Macrolide Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Macrolide Drugs Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Macrolide Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Macrolide Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Macrolide Drugs, Product Type & Application Table 14. Global Macrolide Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Macrolide Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Pharmaceutical Industries Company Information Table 19. Teva Pharmaceutical Industries Business Overview Table 20. Teva Pharmaceutical Industries Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Teva Pharmaceutical Industries Macrolide Drugs Product Portfolio Table 22. Teva Pharmaceutical Industries Recent Developments Table 23. Sanofi Company Information Table 24. Sanofi Business Overview Table 25. Sanofi Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Sanofi Macrolide Drugs Product Portfolio Table 27. Sanofi Recent Developments Table 28. Merck & Co. Company Information Table 29. Merck & Co. Business Overview Table 30. Merck & Co. Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Merck & Co. Macrolide Drugs Product Portfolio Table 32. Merck & Co. Recent Developments Table 33. Mylan Company Information Table 34. Mylan Business Overview Table 35. Mylan Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Mylan Macrolide Drugs Product Portfolio Table 37. Mylan Recent Developments Table 38. Pfizer Company Information Table 39. Pfizer Business Overview Table 40. Pfizer Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Pfizer Macrolide Drugs Product Portfolio Table 42. Pfizer Recent Developments Table 43. Fresenius Kabi Company Information Table 44. Fresenius Kabi Business Overview Table 45. Fresenius Kabi Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Fresenius Kabi Macrolide Drugs Product Portfolio Table 47. Fresenius Kabi Recent Developments Table 48. WOCKHARDT Company Information Table 49. WOCKHARDT Business Overview Table 50. WOCKHARDT Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. WOCKHARDT Macrolide Drugs Product Portfolio Table 52. WOCKHARDT Recent Developments Table 53. Tacorolimus Company Information Table 54. Tacorolimus Business Overview Table 55. Tacorolimus Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Tacorolimus Macrolide Drugs Product Portfolio Table 57. Tacorolimus Recent Developments Table 58. Sirolimus Company Information Table 59. Sirolimus Business Overview Table 60. Sirolimus Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Sirolimus Macrolide Drugs Product Portfolio Table 62. Sirolimus Recent Developments Table 63. Sandoz International Company Information Table 64. Sandoz International Business Overview Table 65. Sandoz International Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Sandoz International Macrolide Drugs Product Portfolio Table 67. Sandoz International Recent Developments Table 68. Neo Química Company Information Table 69. Neo Química Business Overview Table 70. Neo Química Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Neo Química Macrolide Drugs Product Portfolio Table 72. Neo Química Recent Developments Table 73. Macrolide Pharmaceuticals Company Information Table 74. Macrolide Pharmaceuticals Business Overview Table 75. Macrolide Pharmaceuticals Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Macrolide Pharmaceuticals Macrolide Drugs Product Portfolio Table 77. Macrolide Pharmaceuticals Recent Developments Table 78. Gland Pharmm Company Information Table 79. Gland Pharmm Business Overview Table 80. Gland Pharmm Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Gland Pharmm Macrolide Drugs Product Portfolio Table 82. Gland Pharmm Recent Developments Table 83. Eli Lilly & Co. Company Information Table 84. Eli Lilly & Co. Business Overview Table 85. Eli Lilly & Co. Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Eli Lilly & Co. Macrolide Drugs Product Portfolio Table 87. Eli Lilly & Co. Recent Developments Table 88. Akorn Company Information Table 89. Akorn Business Overview Table 90. Akorn Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Akorn Macrolide Drugs Product Portfolio Table 92. Akorn Recent Developments Table 93. Abbott Laboratories Company Information Table 94. Abbott Laboratories Business Overview Table 95. Abbott Laboratories Macrolide Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Abbott Laboratories Macrolide Drugs Product Portfolio Table 97. Abbott Laboratories Recent Developments Table 98. Global Macrolide Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Macrolide Drugs Sales by Region (2021-2026) & (k units) Table 100. Global Macrolide Drugs Sales Market Share by Region (2021-2026) Table 101. Global Macrolide Drugs Sales by Region (2027-2032) & (k units) Table 102. Global Macrolide Drugs Sales Market Share by Region (2027-2032) Table 103. Global Macrolide Drugs Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Macrolide Drugs Revenue Market Share by Region (2021-2026) Table 105. Global Macrolide Drugs Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Macrolide Drugs Revenue Market Share by Region (2027-2032) Table 107. North America Macrolide Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 109. North America Macrolide Drugs Sales by Country (2027-2032) & (k units) Table 110. North America Macrolide Drugs Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Macrolide Drugs Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Macrolide Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 114. Europe Macrolide Drugs Sales by Country (2027-2032) & (k units) Table 115. Europe Macrolide Drugs Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Macrolide Drugs Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Macrolide Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 119. Asia Pacific Macrolide Drugs Sales by Country (2027-2032) & (k units) Table 120. Asia Pacific Macrolide Drugs Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Macrolide Drugs Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Macrolide Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 124. South America Macrolide Drugs Sales by Country (2027-2032) & (k units) Table 125. South America Macrolide Drugs Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Macrolide Drugs Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Macrolide Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 129. Middle East and Africa Macrolide Drugs Sales by Country (2027-2032) & (k units) Table 130. Middle East and Africa Macrolide Drugs Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Macrolide Drugs Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Macrolide Drugs Sales by Type (2021-2026) & (k units) Table 133. Global Macrolide Drugs Sales by Type (2027-2032) & (k units) Table 134. Global Macrolide Drugs Sales Market Share by Type (2021-2026) Table 135. Global Macrolide Drugs Sales Market Share by Type (2027-2032) Table 136. Global Macrolide Drugs Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Macrolide Drugs Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Macrolide Drugs Revenue Market Share by Type (2021-2026) Table 139. Global Macrolide Drugs Revenue Market Share by Type (2027-2032) Table 140. Global Macrolide Drugs Price by Type (2021-2026) & (US$/unit) Table 141. Global Macrolide Drugs Price by Type (2027-2032) & (US$/unit) Table 142. Global Macrolide Drugs Sales by Application (2021-2026) & (k units) Table 143. Global Macrolide Drugs Sales by Application (2027-2032) & (k units) Table 144. Global Macrolide Drugs Sales Market Share by Application (2021-2026) Table 145. Global Macrolide Drugs Sales Market Share by Application (2027-2032) Table 146. Global Macrolide Drugs Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Macrolide Drugs Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Macrolide Drugs Revenue Market Share by Application (2021-2026) Table 149. Global Macrolide Drugs Revenue Market Share by Application (2027-2032) Table 150. Global Macrolide Drugs Price by Application (2021-2026) & (US$/unit) Table 151. Global Macrolide Drugs Price by Application (2027-2032) & (US$/unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Macrolide Drugs Distributors List Table 155. Macrolide Drugs Customers List Table 156. Macrolide Drugs Industry Trends Table 157. Macrolide Drugs Industry Drivers Table 158. Macrolide Drugs Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Macrolide Drugs Product Image Figure 5. Global Macrolide Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Macrolide Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Macrolide Drugs Sales (2021-2032) & (k units) Figure 8. Global Macrolide Drugs Average Price (US$/unit) & (2021-2032) Figure 9. 14-Membered Ring Agents Product Image Figure 10. 15-Membered Ring Agents Product Image Figure 11. 16-Membered Ring Agents Product Image Figure 12. Ketolides Product Image Figure 13. Clinics Product Image Figure 14. Hospitalshospital Pharmacies Product Image Figure 15. Hospitals Product Image Figure 16. Online Pharmacies Product Image Figure 17. Retail Pharmacies Product Image Figure 18. Global Macrolide Drugs Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Macrolide Drugs, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Macrolide Drugs Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Macrolide Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Macrolide Drugs Sales by Region in 2025 Figure 24. Global Macrolide Drugs Revenue by Region in 2025 Figure 25. North America Macrolide Drugs Market Size by Country in 2025 Figure 26. North America Macrolide Drugs Sales Market Share by Country (2021-2032) Figure 27. North America Macrolide Drugs Revenue Market Share by Country (2021-2032) Figure 28. United States Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Mexico Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Macrolide Drugs Market Size by Country in 2025 Figure 32. Europe Macrolide Drugs Sales Market Share by Country (2021-2032) Figure 33. Europe Macrolide Drugs Revenue Market Share by Country (2021-2032) Figure 34. Germany Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Russia Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Spain Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Netherlands Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Switzerland Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Sweden Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Poland Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Asia Pacific Macrolide Drugs Market Size by Country in 2025 Figure 45. Asia Pacific Macrolide Drugs Sales Market Share by Country (2021-2032) Figure 46. Asia Pacific Macrolide Drugs Revenue Market Share by Country (2021-2032) Figure 47. China Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Japan Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South Korea Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. India Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Australia Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Taiwan Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. South America Macrolide Drugs Market Size by Country in 2025 Figure 56. South America Macrolide Drugs Sales Market Share by Country (2021-2032) Figure 57. South America Macrolide Drugs Revenue Market Share by Country (2021-2032) Figure 58. Brazil Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Argentina Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Chile Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Middle East and Africa Macrolide Drugs Market Size by Country in 2025 Figure 62. Middle East and Africa Macrolide Drugs Sales Market Share by Country (2021-2032) Figure 63. Middle East and Africa Macrolide Drugs Revenue Market Share by Country (2021-2032) Figure 64. Egypt Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. South Africa Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Israel Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Türkiye Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. GCC Countries Macrolide Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Global Macrolide Drugs Sales Market Share by Type (2021-2032) Figure 70. Global Macrolide Drugs Revenue Market Share by Type (2021-2032) Figure 71. Global Macrolide Drugs Price (US$/unit) by Type (2021-2032) Figure 72. Global Macrolide Drugs Sales Market Share by Application (2021-2032) Figure 73. Global Macrolide Drugs Revenue Market Share by Application (2021-2032) Figure 74. Global Macrolide Drugs Price (US$/unit) by Application (2021-2032) Figure 75. Macrolide Drugs Value Chain Figure 76. Macrolide Drugs Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Macrolide Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • 14-Membered Ring Agents
  • 15-Membered Ring Agents
  • 16-Membered Ring Agents
  • Ketolides
Applications
  • Clinics
  • Hospitalshospital Pharmacies
  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Teva Pharmaceutical Industries
  • Sanofi
  • Merck & Co.
  • Mylan
  • Pfizer
  • Fresenius Kabi
  • WOCKHARDT
  • Tacorolimus
  • Sirolimus
  • Sandoz International
  • Neo Química
  • Macrolide Pharmaceuticals
  • Gland Pharmm
  • Eli Lilly & Co.
  • Akorn
  • Abbott Laboratories

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Macrolide Drugs Market Size (2021-2032)
  4. 2.2.2 Global Macrolide Drugs Sales (2021-2032)
  5. 2.2.3 Global Macrolide Drugs Market Average Price (2021-2032)
  6. 2.3 Macrolide Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 14-Membered Ring Agents
  9. 2.3.3 15-Membered Ring Agents
  10. 2.3.4 16-Membered Ring Agents
  11. 2.3.5 Ketolides
  12. 2.4 Macrolide Drugs by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Clinics
  15. 2.4.3 Hospitalshospital Pharmacies
  16. 2.4.4 Hospitals
  17. 2.4.5 Online Pharmacies
  18. 2.4.6 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Macrolide Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Macrolide Drugs Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Macrolide Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Macrolide Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Macrolide Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Macrolide Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Macrolide Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Macrolide Drugs, Established Date
  9. 3.9 Global Macrolide Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva Pharmaceutical Industries
  2. 4.1.1 Teva Pharmaceutical Industries Company Information
  3. 4.1.2 Teva Pharmaceutical Industries Business Overview
  4. 4.1.3 Teva Pharmaceutical Industries Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Pharmaceutical Industries Macrolide Drugs Product Portfolio
  6. 4.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 4.2 Sanofi
  8. 4.2.1 Sanofi Company Information
  9. 4.2.2 Sanofi Business Overview
  10. 4.2.3 Sanofi Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sanofi Macrolide Drugs Product Portfolio
  12. 4.2.5 Sanofi Recent Developments
  13. 4.3 Merck & Co.
  14. 4.3.1 Merck & Co. Company Information
  15. 4.3.2 Merck & Co. Business Overview
  16. 4.3.3 Merck & Co. Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Merck & Co. Macrolide Drugs Product Portfolio
  18. 4.3.5 Merck & Co. Recent Developments
  19. 4.4 Mylan
  20. 4.4.1 Mylan Company Information
  21. 4.4.2 Mylan Business Overview
  22. 4.4.3 Mylan Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Mylan Macrolide Drugs Product Portfolio
  24. 4.4.5 Mylan Recent Developments
  25. 4.5 Pfizer
  26. 4.5.1 Pfizer Company Information
  27. 4.5.2 Pfizer Business Overview
  28. 4.5.3 Pfizer Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Pfizer Macrolide Drugs Product Portfolio
  30. 4.5.5 Pfizer Recent Developments
  31. 4.6 Fresenius Kabi
  32. 4.6.1 Fresenius Kabi Company Information
  33. 4.6.2 Fresenius Kabi Business Overview
  34. 4.6.3 Fresenius Kabi Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Fresenius Kabi Macrolide Drugs Product Portfolio
  36. 4.6.5 Fresenius Kabi Recent Developments
  37. 4.7 WOCKHARDT
  38. 4.7.1 WOCKHARDT Company Information
  39. 4.7.2 WOCKHARDT Business Overview
  40. 4.7.3 WOCKHARDT Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 WOCKHARDT Macrolide Drugs Product Portfolio
  42. 4.7.5 WOCKHARDT Recent Developments
  43. 4.8 Tacorolimus
  44. 4.8.1 Tacorolimus Company Information
  45. 4.8.2 Tacorolimus Business Overview
  46. 4.8.3 Tacorolimus Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Tacorolimus Macrolide Drugs Product Portfolio
  48. 4.8.5 Tacorolimus Recent Developments
  49. 4.9 Sirolimus
  50. 4.9.1 Sirolimus Company Information
  51. 4.9.2 Sirolimus Business Overview
  52. 4.9.3 Sirolimus Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Sirolimus Macrolide Drugs Product Portfolio
  54. 4.9.5 Sirolimus Recent Developments
  55. 4.10 Sandoz International
  56. 4.10.1 Sandoz International Company Information
  57. 4.10.2 Sandoz International Business Overview
  58. 4.10.3 Sandoz International Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Sandoz International Macrolide Drugs Product Portfolio
  60. 4.10.5 Sandoz International Recent Developments
  61. 4.11 Neo Química
  62. 4.11.1 Neo Química Company Information
  63. 4.11.2 Neo Química Business Overview
  64. 4.11.3 Neo Química Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Neo Química Macrolide Drugs Product Portfolio
  66. 4.11.5 Neo Química Recent Developments
  67. 4.12 Macrolide Pharmaceuticals
  68. 4.12.1 Macrolide Pharmaceuticals Company Information
  69. 4.12.2 Macrolide Pharmaceuticals Business Overview
  70. 4.12.3 Macrolide Pharmaceuticals Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Macrolide Pharmaceuticals Macrolide Drugs Product Portfolio
  72. 4.12.5 Macrolide Pharmaceuticals Recent Developments
  73. 4.13 Gland Pharmm
  74. 4.13.1 Gland Pharmm Company Information
  75. 4.13.2 Gland Pharmm Business Overview
  76. 4.13.3 Gland Pharmm Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Gland Pharmm Macrolide Drugs Product Portfolio
  78. 4.13.5 Gland Pharmm Recent Developments
  79. 4.14 Eli Lilly & Co.
  80. 4.14.1 Eli Lilly & Co. Company Information
  81. 4.14.2 Eli Lilly & Co. Business Overview
  82. 4.14.3 Eli Lilly & Co. Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Eli Lilly & Co. Macrolide Drugs Product Portfolio
  84. 4.14.5 Eli Lilly & Co. Recent Developments
  85. 4.15 Akorn
  86. 4.15.1 Akorn Company Information
  87. 4.15.2 Akorn Business Overview
  88. 4.15.3 Akorn Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Akorn Macrolide Drugs Product Portfolio
  90. 4.15.5 Akorn Recent Developments
  91. 4.16 Abbott Laboratories
  92. 4.16.1 Abbott Laboratories Company Information
  93. 4.16.2 Abbott Laboratories Business Overview
  94. 4.16.3 Abbott Laboratories Macrolide Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Abbott Laboratories Macrolide Drugs Product Portfolio
  96. 4.16.5 Abbott Laboratories Recent Developments
5 Global Macrolide Drugs Market Scenario by Region
  1. 5.1 Global Macrolide Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Macrolide Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Macrolide Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Macrolide Drugs Sales by Region: 2027-2032
  5. 5.3 Global Macrolide Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Macrolide Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Macrolide Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Macrolide Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Macrolide Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Macrolide Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Macrolide Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Macrolide Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Macrolide Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Macrolide Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Macrolide Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Macrolide Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Macrolide Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Macrolide Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Macrolide Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Macrolide Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Macrolide Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Macrolide Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Macrolide Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Macrolide Drugs Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Macrolide Drugs Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Macrolide Drugs Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Macrolide Drugs Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Macrolide Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Macrolide Drugs Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Macrolide Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Macrolide Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Macrolide Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Macrolide Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Macrolide Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Macrolide Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Macrolide Drugs Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Macrolide Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Macrolide Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Macrolide Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Macrolide Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Macrolide Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Macrolide Drugs Value Chain Analysis
  2. 8.1.1 Macrolide Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Macrolide Drugs Production Mode & Process
  5. 8.2 Macrolide Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Macrolide Drugs Distributors
  8. 8.2.3 Macrolide Drugs Customers
9 Global Macrolide Drugs Analyzing Market Dynamics
  1. 9.1 Macrolide Drugs Industry Trends
  2. 9.2 Macrolide Drugs Industry Drivers
  3. 9.3 Macrolide Drugs Industry Opportunities and Challenges
  4. 9.4 Macrolide Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst